女女女女女女BBBBBB毛,白嫩外女BBWBBWBBW,妖小槡BBBB槡BBBB槡,女BBBB槡BBBB槡BBBB,另类老妇性BBWBBW,另类老妇奶性生BBWBBW,凸凸凹BBWBBWBBWBBW,特级BBBBBBBBB视频,四川少妇BBW搡BBBB槡BBBB,人妻少妇偷人精品无码_国模大胆一区二区三区_精品无码一区二区三区亚洲桃色_国产精品99久久久久久宅男 ,精品人无码一区二区三区_亚洲精品国产精品国自产_国产精品99久久久久久猫咪_99久久久无码国产精品免费 ,国产亚洲精品免费视频播放_日韩成人在线视屏_亚洲日韩在线第一页_无码人妻精品一区二区蜜桃AV_中文自拍日本综合_亚洲中久无码不卡永久在线观看_免费观看四虎精品成人_国产青草视频在线观看_国产欧美亚洲精品综合第一页_中文字幕在线永久

    Made up by three brand exhibitions, the 75th CMEF, the 75th CQMC and the 76th API; the Health Industry Summit held from April 17th to 20th 2016 is definitely the greatest grand meeting in healthcare industry. Initiated in 1968, the 76th API China & PHARMEX & PHARMPACK & SINOPHEX& PHARMEX, API China for short, was opened on April 18th, and it could be called as the long-standing exhibition with the longest history in Chinese pharmaceuticals.

    For the reason that the current API China covers fifty thousand kinds of APIs from 24 classes, as well as all required auxiliary materials, exterior and interior packing materials, manufacturing and inspection equipments for the production of medicine and healthcare products; it’s not only the effective “one-stop” purchasing platform for overseas and domestic enterprises on production of medicine and healthcare products, but also an excellent opportunity for comprehensively understanding the development trend of Chinese pharmaceutical and healthcare industries, making the acquaintance with partners within the same industry, and discovering new business opportunities.

    At the beginning of 2016, there were so many policies for pharmaceutical industry coming into being which simultaneously brought about forceful challenges and survival pressures and created unique opportunities for many excellent enterprises to stand out in the process of new round industry reshuffling. Generally speaking, Chinese pharmaceutical industry would expand the competitions on the two themes of “Promotion on Medicine Quality” and “Moving forward the Public Health Industry ” for a long period in the future. The 76th API China is exactly the place of strategic importance in which pharmaceutical and healthcare enterprises could take good use of the two trends and seize the advanced chances.

    Minxiang Biomedicalparticipated in the exhibition along with its series products of adamantane, hypoglycemic drugs (Statins) and medical intermediate, biological and fermented products. During the two-day-long exhibition, Minxiang Biomedical fully demonstrated the advantages of its products, obtained the appreciationsfrom lots of partners and participants, grasped the latest development trend of medical industry, won numerous cooperationopportunities and broadened its visions and markets.

    Aimed at the rapid expanding of “Public Health Industry”, Minxiang Biomedical would stick to the development concept of “Aspire to Innovations, and Innovate the Quality”, research and development and produce more advanced products, and seize the opportunities by its strength.